Temporal trends of incidence and survival of sarcoma of digestive tract including Gastrointestinal Stromal Tumours (GIST) in two areas of the north-east of Spain in the period 1981-2005: A population-based study

Clinical and Translational Oncology

Volumn 16, Issue 7, 2014, Pages 660-667

  Rubio Casadevall J ^a,b,c   Borras J L ^d,e   Carmona, C ^f   Ameijide, A ^c,g   Osca, G ^b,f,h   Vilardell, L ^f   Izquierdo, A ^a,f   Galceran, J ^g   Marcos Gragera, R ^b,f,h  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^e UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^f GENERALITAT DE CATALUNYA   (Spain)

^g Tarragona Cancer Registry   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Epidemiology; Gastrointestinal stromal tumours; Incidence; Registries; Sarcoma; Survival

Indexed keywords

ADULT; AGED; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMAN; INCIDENCE; MALE; MIDDLE AGED; REGISTER; SARCOMA; SPAIN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; SARCOMA; SPAIN;

EID: 84905689339     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1131-0     Document Type: Article

References (22)

1. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577-80. (Pubitemid 28067289)
2. Mazur MT, Clark HB. Gastric stromal tumors: reappraisal of histogenesis. Am J Surg Pathol. 1983;7:507-19. (Pubitemid 13021488)
3. Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459-65. (Pubitemid 34747864)
4. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Volume VIII. IARC Scientific Publication no. 155. 2002.
5. Jensen OM, Storm HH. Reporting of results. In: Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods, vol 95. IARC Sci Publ 1991. p. 108-25.
6. International Classification of Diseases for Oncology. 1st ed. Geneva: World Health Organization edition; 1976
7. Percy C, Van Holten V, Muir CS. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organisation edition; 1990.
8. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan SL. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization edition; 2000.
9. Rubió J, Marcos-Gragera R, Ortiz MR, Miró J, Vilardell L, Gironès J, et al. Population-based incidence and survival of gastrointestinal stromal tumors (GIST) in Girona, Spain. Eur J Cancer. 2007;43:144-8. (Pubitemid 46054472)
10. Martos MC, Saurina C, Feja C, Saez M, Burriel MC, Barcelo MA, et al. Accurately estimating breast cancer survival in Spain: cross-matching local cancer registries with the National Death Index. Rev Panam Salud Publica. 2009;26(1):51-4.
11. Esteve J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival. Elements for further discussion. Stat Med 1990; 9:529-38. (Pubitemid 20235022)
12. Hakulinen T. Cancer survival corrected for heterogeneity in patients withdrawal. Biometrics. 1982;38:933-42.
13. Fleming TH, Harrington DP. Nonparametric estimation of the survival distribution in censored data. Commun Stat. 1984;2012(13):2469-86.
14. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation test for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-51. (Pubitemid 30070608)
15. Miettinen M, Lasota J. Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438:1-12. (Pubitemid 32128184)
16. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52-68. (Pubitemid 40023952)
17. Steigen SE, Eide TJ. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of Northern Norway. APMIS. 2006;114:192-200.
18. Goettsch WG, Bos SD, Breekveldt-Postma N, Casparie M, Herings R, Hogendoorn P. Incidence of gastrointestinal stromal tumors is underestimated: results of a nation-wide study. Eur J Cancer. 2005;41:2868-72. (Pubitemid 41713125)
19. Cho MY, Sohn JE, Kim JM, Kim KM, Park YS, Kim WH, et al. Current trends in the epidemiological and pathological characteristics of Gastrointestinal Stromal Tumors in Korea, 2003-2004. J Korean Med Sci. 2010;25:853-62.
20. Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course and prognostication in the pre-imatinib mesylate era: a population based study in Western Sweden. Cancer. 2005;103(4):821-9. (Pubitemid 40216412)
21. Tryggvason G, Gíslason HG, Magnússon MK, Jónasson JG. The Icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005;117:289-93.
22. Mucciarini C, Rossi G, Bertolini F, Valli R, Cirilli C, Rashid I, et al. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer. 2007;7:230-7.